Supplier profile
NOVARTIS FARMACEUTICA, S.A.
Every public-sector award we hold for this supplier, across Spain, from 3 Nov 2008 to 8 Oct 2026.
Awards won
1,163
all time
Attributed value
€1.5bn
209 shared, unvalued
Buyers
311
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Dirección Gerencia del Complejo Hospitalario Universitario de Canarias | 96 | €35.5m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 95 | €19.6m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 68 | €18.6m |
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 58 | €18.8m |
| Servicio Madrileno de Salud, Hospital Universitario La Paz | 25 | €23.8m |
| Gerencia de Servicio Sanitarios de Fuerteventura | 21 | €3.9m |
| Osakidetza | 20 | €40.1m |
| Inspección General de Sanidad de la Defensa | 19 | €2.2m |
| Dirección General de Planificación Económica | 17 | €42.1m |
| Consorci Sanitari Integral | 16 | €1.7m |
What they win
Awards
Showing 26–50 of 1,163 awards we hold
- Spain – Antineoplastic agents – Scemblix 40 mg comprimidos recubiertos con película ↗HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS€236kawarded 11 Jun 2026
- Spain – Various medicinal products – PNSP HUPA 45/26 ↗HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS€334kawarded 11 Jun 2026
- Suministro del medicamento inclisirán 248 mg solución inyectable en jeringa precargada mediante procedimientos negociado sinpublicidad, sin concurrencia de ofertas y tramitación ordinaria con destino el Servicio de Farmacia del Hospital UniversitarioNtra. Sra. de Candelaria. ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€73kawarded 9 Jun 2026
- Spain – Various medicinal products – Acuerdo Marco del Suministro del MEDICAMENTO RANIBIZUMAB ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 9 Jun 2026
- Spain – Pharmaceutical products – SUMINISTRO DE IPTACOPAN (FABHALTA) DE DISTRIBUCION EXCLUSIVA DEL LABORATORIO NOVARTIS FARMACÉUTICA, S.A. CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS DE MADRID ↗HOSPITAL CLINICO SAN CARLOS DE MADRID€1.3mawarded 5 Jun 2026
- Spain – Various medicinal products – Suministro de los productos farmacéuticos Mavacamten, Inclisirán y Aripiprazol para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€279kawarded 5 Jun 2026
- Spain – Pharmaceutical products – JAEN 1º CBAM NOVARTIS FARMACEÚTICA, S.A. AM CC 578/2025 ↗Servicio Andaluz de Salud. Hospital Universitario de Jaén€1.7mawarded 2 Jun 2026
- Spain – Pharmaceutical products – ALMERIA 1º CBAM CONTR 2026 0000201916_1 ↗Servicio Andaluz de Salud. Central Provincial de Compras de Almería€950kawarded 2 Jun 2026
- Spain – Pharmaceutical products – CONTR 2026 200941 CBAM-1 GRANADA AMC 2204-2025 (578/2025) MEDICAMENTOS EXCLUSIVOS ↗Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nievesawarded 29 May 2026
- Spain – Pharmaceutical products – Suministro de medicamentos exclusivos Brolucizumab (BEOVU), Everolimus (VOTUBIA), Inclisiran (LEQVIO), Ceritinib (ZYKADIA) y Asciminib (SCEMBLIX) y Gozetotida 68GA (LOCAMETZ). ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€841kawarded 28 May 2026
- Spain – Isotopic reagents – Suministro del principio activo Gozetotida 25 microgramos, equipo reactivo para preparación radio farmacéutica, con destino al Servicio de Medicina Nuclear del Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria ↗Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil€183kawarded 26 May 2026
- Spain – Pharmaceutical products – Suministro farmacéutico del principio activo Asciminib 40 mg y Asciminib 20 mg. ↗Gerencia de Servicio Sanitarios de Fuerteventura€170kawarded 22 May 2026
- Spain – Pharmaceutical products – Suministro de medicamentos exclusivos de la empresa NOVARTIS FARMACEUTICA, S.A., con destino a los pacientes del INGESA en el Área Sanitaria de Melilla ↗Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria€1.3mawarded 19 May 2026
- Spain – Other therapeutic products – Suministro de Lutecio (177LU) Vipivotida Tetraxetán 1000 MBq/ml solución inyectable y para perfusión, 1 vial ↗Gerencia del Área Sanitaria IV del Servicio de Salud del Principado de Asturias€1.3mawarded 19 May 2026
- Suministro de medicamentos exclusivos de la empresa NOVARTIS FARMACEUTICA, S.A., con destino a los pacientes del INGESA en el Área Sanitaria de Melilla ↗Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria€1.3mawarded 18 May 2026
- Spain – Isotopic reagents – Suministro de radiofarmacos para el tratamiento y diagnóstico de cáncer de próstata, lesiones suprarrenales y malabsorción de sales biliares con destino al Servicio de Medicina Nuclear del Hospital General Universitario Gregorio Marañón ↗Hospital G. U. Gregorio Marañónshared awardawarded 15 May 2026
- Spain – Various medicinal products – Suministro de medicamentos analgésicos y antiinflamatorios subgrupos terapéuticos N02 y M01 respectivamente, con destino al Área Sanitaria de Ceuta ↗Gerencia de Atención Sanitaria del Instituto Nacional de Gestión Sanitaria en Ceutashared awardawarded 14 May 2026
- Spain – Radio-isotopes – Suministro de radiofármacos PET a los centros del Instituto de Diagnóstico por la Imagen ↗INSTITUT DE DIAGNÒSTIC PER LA IMATGEshared awardawarded 9 May 2026
- Spain – Various medicinal products – d_sanitaria_acuerdo marco_ medicamentos exclusivos III ↗Servicio de Salud - Servicios Centralesshared awardawarded 8 May 2026
- Spain – Pharmaceutical products – SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: ERENUMAB (AIMOVIG), BACLOFENO (LIORESAL INTRATECAL), OCTEOTRIDO IM (SANDOSTATIN LAR), EVEROLIMUS INMUNOSUPRESOR (CERTICAN), RIBOCICLIB (KISQALI) Y LAPATINIB (TYVERB). ↗Servicio Madrileno de Salud, Hospital Universitario La Paz€91kawarded 21 Apr 2026
- Spain – Various medicinal products – suministro del principio activo denominado "ASCIMINIB 40 MG oral" ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€141kawarded 17 Apr 2026
- Spain – Medicinal products for the alimentary tract and metabolism – Suministro de diversos medicamentos exclusivos con destino a los centros sanitarios dependientes de la Gerencia Regional de Salud de Castilla y León ↗Gerencia Regional de Salud de Castilla y Leónshared awardawarded 17 Apr 2026
- Spain – Pharmaceutical products – A.M suministros CONTR 2025 0000519166 ↗Servicio Andaluz de Salud. Servicios Centralesshared awardawarded 16 Apr 2026
- Spain – Pharmaceutical products – Suministro de medicamentos para el Hospital Universitari Vall d'Hebrón ↗ICS - Hospital Universitari Vall Hebron€3.5mawarded 9 Apr 2026
- Spain – Pharmaceutical products – Acuerdo Marco de Medicamentos ↗Gerencia del Hospital Intermutual de Levanteshared awardawarded 9 Apr 2026
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.